Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Lysibodies are IgG Fc fusions with lysin binding domains targeting Staphylococcus aureus wall carbohydrates for effective phagocytosis.

Raz A, Serrano A, Lawson C, Thaker M, Alston T, Bournazos S, Ravetch JV, Fischetti VA.

Proc Natl Acad Sci U S A. 2017 May 2;114(18):4781-4786. doi: 10.1073/pnas.1619249114. Epub 2017 Apr 20.

PMID:
28428342
2.

Staphylococcus aureus vaccines: Deviating from the carol.

Missiakas D, Schneewind O.

J Exp Med. 2016 Aug 22;213(9):1645-53. doi: 10.1084/jem.20160569. Epub 2016 Aug 15. Review.

3.

Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses.

Nishat S, Andreana PR.

Vaccines (Basel). 2016 May 20;4(2). pii: E19. doi: 10.3390/vaccines4020019. Review.

4.

Vaccines for Healthcare-associated Infections: Promise and Challenge.

Knisely JM, Liu B, Ranallo RT, Zou L.

Clin Infect Dis. 2016 Sep 1;63(5):657-62. doi: 10.1093/cid/ciw333. Epub 2016 May 20.

5.

Envelope Structures of Gram-Positive Bacteria.

Rajagopal M, Walker S.

Curr Top Microbiol Immunol. 2017;404:1-44. doi: 10.1007/82_2015_5021. Review.

PMID:
26919863
6.

Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.

Sause WE, Buckley PT, Strohl WR, Lynch AS, Torres VJ.

Trends Pharmacol Sci. 2016 Mar;37(3):231-41. doi: 10.1016/j.tips.2015.11.008. Epub 2015 Dec 22. Review.

7.

Prevention and treatment of Staphylococcus aureus biofilms.

Bhattacharya M, Wozniak DJ, Stoodley P, Hall-Stoodley L.

Expert Rev Anti Infect Ther. 2015;13(12):1499-516. doi: 10.1586/14787210.2015.1100533. Epub 2015 Nov 13. Review.

8.

Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.

Levy J, Licini L, Haelterman E, Moris P, Lestrate P, Damaso S, Van Belle P, Boutriau D.

Hum Vaccin Immunother. 2015;11(3):620-31. doi: 10.1080/21645515.2015.1011021.

9.

Active immunization with an octa-valent Staphylococcus aureus antigen mixture in models of S. aureus bacteremia and skin infection in mice.

van den Berg S, Koedijk DG, Back JW, Neef J, Dreisbach A, van Dijl JM, Bakker-Woudenberg IA, Buist G.

PLoS One. 2015 Feb 24;10(2):e0116847. doi: 10.1371/journal.pone.0116847. eCollection 2015.

10.

Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs.

Kim HK, Falugi F, Thomer L, Missiakas DM, Schneewind O.

MBio. 2015 Jan 6;6(1). pii: e02369-14. doi: 10.1128/mBio.02369-14.

11.

Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.

Yeaman MR, Filler SG, Schmidt CS, Ibrahim AS, Edwards JE Jr, Hennessey JP Jr.

Front Immunol. 2014 Sep 26;5:463. doi: 10.3389/fimmu.2014.00463. eCollection 2014. Review.

12.

Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection.

Rauch S, Gough P, Kim HK, Schneewind O, Missiakas D.

Infect Immun. 2014 Nov;82(11):4889-98. doi: 10.1128/IAI.02328-14. Epub 2014 Sep 2.

13.

The comparison of Staphylococcus aureus types 5 and 8 with respect to methicillin resistance in patients admitted to Al-Zahra Hospital by PCR.

Havaei SA, Moghim S, Bardebari AM, Narimani T, Azimian A, Akbari M.

Adv Biomed Res. 2013 Mar 6;2:13. doi: 10.4103/2277-9175.107962. Print 2013.

14.

Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials.

Bagnoli F, Bertholet S, Grandi G.

Front Cell Infect Microbiol. 2012 Feb 22;2:16. doi: 10.3389/fcimb.2012.00016. eCollection 2012. Review. No abstract available.

15.

Comparison of Capsular Typing of Staphylococcus aureus with Bacteriophage Typing: A Study in Gulbarga, India.

Paul-Satyaseela M, Shivannavar CT, Gaddad SM.

Indian J Microbiol. 2011 Jul;51(3):359-62. doi: 10.1007/s12088-011-0108-3. Epub 2011 Feb 14.

16.

Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model.

Joshi A, Pancari G, Cope L, Bowman EP, Cua D, Proctor RA, McNeely T.

Hum Vaccin Immunother. 2012 Mar;8(3):336-46. doi: 10.4161/hv.18946. Epub 2012 Feb 13.

17.

CD4 T cell antigens from Staphylococcus aureus Newman strain identified following immunization with heat-killed bacteria.

Lawrence PK, Rokbi B, Arnaud-Barbe N, Sutten EL, Norimine J, Lahmers KK, Brown WC.

Clin Vaccine Immunol. 2012 Apr;19(4):477-89. doi: 10.1128/CVI.05642-11. Epub 2012 Feb 8.

18.

Exploring Staphylococcus aureus pathways to disease for vaccine development.

DeDent A, Kim HK, Missiakas D, Schneewind O.

Semin Immunopathol. 2012 Mar;34(2):317-33. doi: 10.1007/s00281-011-0299-z. Epub 2011 Dec 1. Review.

19.

Recurrent infections and immune evasion strategies of Staphylococcus aureus.

Kim HK, Thammavongsa V, Schneewind O, Missiakas D.

Curr Opin Microbiol. 2012 Feb;15(1):92-9. doi: 10.1016/j.mib.2011.10.012. Epub 2011 Nov 14. Review.

20.

Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment.

Brady RA, O'May GA, Leid JG, Prior ML, Costerton JW, Shirtliff ME.

Infect Immun. 2011 Apr;79(4):1797-803. doi: 10.1128/IAI.00451-10. Epub 2011 Jan 10.

Supplemental Content

Support Center